Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study-Reference-Cited by-同舟云学术

Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study

Published:2024-05 Issue:5 Volume:5 Page:e452-e458
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Fountain-Jones Nicholas M^ORCID,Vanhaeften Robert,Williamson Jan,Maskell Janelle,Chua I-Ly J,Charleston Michael,Cooley Louise

Funder

Australian Research Council

Publisher

Elsevier BV

Reference16 articles.

1. Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection;Karim;medRxiv,2021

2. Detection of a SARS-CoV-2 variant of concern in South Africa;Tegally;Nature,2021

3. An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19;Singh;Diabetes Metab Syndr,2022

4. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis;Kabinger;Nat Struct Mol Biol,2021

5. A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes;Sanderson;Nature,2023

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long COVID: current management and future prospects;COVID-19: An Update;2024-09-01

2. The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19;Seminars in Hematology;2024-08

3. Emergence and fixation of SARS‐CoV‐2 minority variants in a chronically infected patient receiving therapy in Denmark;APMIS;2024-07-03

4. Molnupiravir increases SARS‐CoV‐2 genome diversity and complexity: A case‐control cohort study;Journal of Medical Virology;2024-05